Span Divergent P/E Ratio
Span Divergent P/E ratio. Span Divergent (SDL) P/E ratio is not applicable — EPS (TTM) ₹-2.33, 3 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 3 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 3
Current EPS: ₹-2.33
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -0.34 | 0 | Loss |
| Mar 2025 | -1.87 | -1 | Loss |
| Jun 2025 | -0.31 | 0 | Loss |
| Sept 2024 | 0.09 | 0 | Profit |
| Mar 2024 | 1.62 | 1 | Profit |
| Jun 2024 | -0.16 | 0 | Loss |
| Dec 2024 | -0.39 | 0 | Loss |
| Sept 2023 | -0.55 | 0 | Loss |
Healthcare Peers with Valid P/E Ratios — SDL Comparison
Healthcare sector average P/E 56.2, median 32.5 — SDL excluded (negative EPS).
Sector Average PE
56.2
Sector Median PE
32.5
Lowest PE
2.04
Profitable Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Span Divergent share price chart.
- Examine SDL Q4 results for recent quarterly revenue, profit and EPS trends.
- Also explore Span Divergent share price performance to track price trends across different timeframes.